Jonathan Strosberg, MD, Associate Professor, Section Head, Neuroendocrine Tumor Program at Moffitt Cancer Center

Jonathan Strosberg, MD, Associate Professor, Section Head, Neuroendocrine Tumor Program at Moffitt Cancer Center

Dr. Strosberg was lead investigator for the NETTER-1 trial—sponsored by Novartis’ Advanced Accelerator Applications.  He says “There are very few effective treatment options for patients with inoperable, advanced GEP-NETs who are progressive on somatostatin analogues....

Pin It on Pinterest